References
Schwedler G, Lindinger A, Lange PE, Sax U, Olchvary J, Peters B, Bauer U, Hense HW (2011) Frequency and spectrum of congenital heart defects among live births in Germany: a study of the competence network for congenital heart defects. Clin Res Cardiol 100(12):1111–1117
Al-Hamash SM, Wahab HA, Khalid ZH, Nasser IV (2012) Transcatheter closure of patent ductus arteriosus using ado device: retrospective study of 149 patients. Heart Views 13(1):1–6
Moore JW, Levi DS, Moore SD, Schneider DJ, Berdjis F (2005) Interventional treatment of patent ductus arteriosus in 2004. Catheter Cardiovasc Interv 65:91–101
Eicken A, Balling G, Gildein HP, Genz T, Kaemmerer H, Hess J (2007) Transcatheter closure of a non-restrictive patent ductus arteriosus with an Amplatzer muscular ventricular septal defect occluder. Int J Cardiol 117(1):e40–e42 Epub 2006 Dec 29
Spies C, Ujivari F, Schräder R (2005) Transcatheter closure of a 22 mm patent ductus arteriosus with an Amplatzer atrial septal occluder. Catheter Cardiovasc Interv 64(3):352–355
Baumgartner H, Bonhoeffer P, Groot NM et al (2010) Guidelines for the management of grown-up congenital heart disease (new version 2010): the task force on the management of grown-up congenital heart disease of the European society of cardiology (ESC), endorsed by the Association for European paediatric cardiology (AEPC). Eur Heart J 31:2915–2957
Faella HJ, Hijazi ZM (2000) Closure of the patent ductus arteriosus with the amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv 51:50–54
Demkow M, Ruzyllo W, Siudalska H, Kepka C (2001) Transcatheter closure of a 16 mm hypertensive patent ductus arteriosus with the Amplatzer muscular VSD occluder. Catheter Cardiovasc Interv 52(3):359–362
Onorato E, Mbala-Mukendi M, Casilli F, Girardi P, Canali G, Lanzoni L, Guilarte N, Barbieri E (2004) Amplatzer Muscular VSD occluder for catheter closure of a 20 mm hypertensive patent ductus arteriosus. A case report and literature review. Minerva Cardioangiol 52(3):219–223
Zhang ZN, Jiang X, Zhang R, Li XL, Wu BX, Zhao QH, Wang Y, Dai LZ, Pan L, Gomberg-Maitland M, Jing ZC (2011) Oral sildenafil treatment for Eisenmenger syndrome: a prospective, open-label, multicentre study. Heart 97(22):1876–1881
Franz IW, Van Der Meyden J, Schaupp S, Tönnesmann U (2002) The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease. Z Kardiol 91(10):833–839
Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M, Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators (2006) Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Circulation 114(1):48–54
Acknowledgments
Hospital funding. This research received no specific grant from any funding agency, commercial or not-for-profit sectors.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Froehle, M., Haas, N.A., Sandica, E. et al. Percutaneous closure of a gigantic patent ductus arteriosus (PDA) with pulmonary hypertension with an atrial septal defect occluder in a 35-year-old woman. Clin Res Cardiol 103, 319–323 (2014). https://doi.org/10.1007/s00392-013-0650-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-013-0650-6